Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.5050 (1.56%) ($7.5050 - $7.5050) on Wed. Sep. 27, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.29% (three month average) | RSI | 64 | Latest Price | $7.5050(1.56%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 1% a day on average for past five trading days. | Weekly Trend | BCRX advances 3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XOP(37%) TBT(31%) VIXM(23%) ACES(22%) TLT(13%) | Factors Impacting BCRX price | BCRX will decline at least -1.645% in a week (0% probabilities). ICLN(-47%) IFRA(-35%) IDRV(49%) IWD(-28%) IWO(-49%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -1.645% (StdDev 3.29%) | Hourly BBV | 1.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $7.36(1.97%) | 10 Day Moving Average | $7.3(2.81%) | 20 Day Moving Average | $7.16(4.82%) | To recent high | -4.8% | To recent low | 12% | Market Cap | $1.324b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |